Search results
Results from the WOW.Com Content Network
Citalopram, sold under the brand name Celexa among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [7] [10] It is used to treat major depressive disorder, obsessive compulsive disorder, panic disorder, and social phobia. [7] The antidepressant effects may take one to four weeks to occur. [7]
Citalopram (Celexa) is an SSRI used to treat depression. It was first approved in 1998 by the FDA. ... some people who don’t respond to an SSRI will do well on an SNRI. SNRI drugs are widely ...
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.
Dual inhibition of serotonin and noradrenaline reuptake can offer advantages over other antidepressant drugs by treating a wider range of symptoms. [3] They can be especially useful in concomitant chronic or neuropathic pain. [4] SNRIs, along with SSRIs and NRIs, are second-generation antidepressants.
Vyvanse (lisdexamfetamine) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder; Vyvanse is converted into Dexedrine in vivo; Viibryd – an antidepressant of the serotonin modulator and stimulators class; Vivactil (protriptyline) an antidepressant also used in the treatment of nerve pain
Bupropion is often used as an alternative to SSRIs or as a secondary medication in combination with an SSRI or SNRI because it’s less likely to cause intimate side effects. Although bupropion is ...
SSRIs and SNRIs — two of the most commonly prescribed antidepressants — cause intimate dysfunction in 25 to 73 percent and 58 to 70 percent of users, respectively.
Post-SSRI sexual dysfunction (PSSD) [63] [64] refers to a set of symptoms reported by some people who have taken SSRIs or other serotonin reuptake-inhibiting (SRI) drugs, in which sexual dysfunction symptoms persist for at least three months [65] [66] [67] after ceasing to take the drug. The status of PSSD as a legitimate and distinct pathology ...